Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Child Development Disorders, Pervasive

3,4-dihydroxyphenylacetic acid has been researched along with Child Development Disorders, Pervasive in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Child Development Disorders, Pervasive: Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hameury, L1
Roux, S1
Barthélémy, C1
Adrien, JL1
Desombre, H1
Sauvage, D1
Garreau, B1
Lelord, G1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Child Development Disorders, Pervasive

ArticleYear
Quantified multidimensional assessment of autism and other pervasive developmental disorders. Application for bioclinical research.
    European child & adolescent psychiatry, 1995, Volume: 4, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Autistic Disorder; Brain; Child; Child Development Disor

1995